DAEJEON, South Korea, June 20, 2024 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ: 226330), an artificial intelligence (AI) based drug development company, announced the signing of a strategic Memorandum of ...
SAN DIEGO and NEWARK, Del., April 28, 2026 /PRNewswire/ -- Recently, ACROBiosystems was honored as a "Protein Supplier to Watch in Cancer Research in 2026" at the CiteAb Awards. CiteAb accelerates ...
The innovative development of biopharmaceuticals relies on stable, legally compliant R&D tools. Functional cell lines serve as a versatile vital engine driving full-cycle breakthroughs in innovative ...
NEWARK, Del., July 18, 2024 /PRNewswire/ -- At the recent International Society for Stem Cell Research (ISSCR) Annual Meeting in Hamburg, ACROBiosystems announced its new GMP-centered brand, Resilient ...
- Leading Scientists from China, Japan and South Korea Convene to Drive Organoid Research and Commercialization Rosanna Zhang, Vice President of ACROBiosystems, discussed innovative uses of organoids ...
SAN FRANCISCO, Feb. 2, 2026 /PRNewswire/ -- On January 11, as the global healthcare industry gathered in San Francisco, the BIOSeedin Winter Innovation Partnering Summit successfully convened ahead of ...
A Aaa Aaaaaaaaaa 4,942.0 +19.20% 5,890.9 ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results